slotkoers
Korea S.E.
00:00:00 24-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.625
KRW
|
+2,11%
|
|
-3,33%
|
-39,88%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
5.131.552
|
1.033.808
|
866.567
|
1.243.785
|
716.461
|
619.837
|
Bedrijfswaarde
1 |
5.021.763
|
985.877
|
860.153
|
1.139.382
|
656.589
|
580.236
|
K/w-verhouding
|
-90,5
x
|
-9,09
x
|
-18,1
x
|
-63,9
x
|
-29,1
x
|
-30,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
665
x
|
114
x
|
519
x
|
4.890
x
|
143
x
|
157
x
|
Bedrijfswaarde/omzet
|
651
x
|
109
x
|
515
x
|
4.479
x
|
131
x
|
147
x
|
Bedrijfswaarde/EBITDA
|
-90,1
x
|
-17,9
x
|
-26,1
x
|
-59,2
x
|
-28,2
x
|
-28,5
x
|
Bedrijfswaarde/FCF
|
-195
x
|
-26,1
x
|
-35,8
x
|
-224
x
|
-18,1
x
|
-44,1
x
|
FCF Yield
|
-0,51%
|
-3,83%
|
-2,79%
|
-0,45%
|
-5,53%
|
-2,27%
|
Price to Book
|
31,1
x
|
16,9
x
|
37,8
x
|
11,5
x
|
9,08
x
|
10,8
x
|
Aantal aandelen (in duizenden)
|
69.817
|
71.052
|
71.617
|
102.792
|
102.792
|
102.792
|
Referentieprijs
2 |
73.500
|
14.550
|
12.100
|
12.100
|
6.970
|
6.030
|
Datum van publicatie
|
19-03-19
|
30-03-20
|
22-03-21
|
22-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
7.712
|
9.069
|
1.670
|
254,4
|
5.013
|
3.940
|
EBITDA
1 |
-55.740
|
-55.149
|
-32.933
|
-19.239
|
-23.248
|
-20.326
|
Bedrijfsresultaat (EBIT)
1 |
-59.279
|
-58.493
|
-34.661
|
-20.378
|
-24.447
|
-21.472
|
Operationele Marge
|
-768,66%
|
-645%
|
-2.075,86%
|
-8.011,5%
|
-487,63%
|
-545,04%
|
Resultaat voor belastingen (EBT)
1 |
-55.433
|
-113.196
|
-47.825
|
-22.124
|
-23.901
|
-20.181
|
Nettowinst (verlies)
1 |
-56.236
|
-113.200
|
-47.825
|
-16.006
|
-24.593
|
-20.369
|
Nettomarge
|
-729,2%
|
-1.248,27%
|
-2.864,25%
|
-6.292,62%
|
-490,55%
|
-517,04%
|
WPA
2 |
-812,0
|
-1.600
|
-668,0
|
-189,3
|
-239,3
|
-198,2
|
Free Cash Flow
1 |
-25.788
|
-37.751
|
-23.999
|
-5.084
|
-36.328
|
-13.156
|
FCF-marge
|
-334,39%
|
-416,29%
|
-1.437,32%
|
-1.998,65%
|
-724,62%
|
-333,94%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
19-03-19
|
30-03-20
|
22-03-21
|
22-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
109.789
|
47.932
|
6.414
|
104.403
|
59.872
|
39.600
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-25.788
|
-37.751
|
-23.999
|
-5.084
|
-36.328
|
-13.156
|
ROE (netto-inkomsten/eigen vermogen)
|
-30,6%
|
-100%
|
-114%
|
-24,5%
|
-26,3%
|
-29,9%
|
ROA (netto-inkomsten/totale activa)
|
-17,3%
|
-27,8%
|
-37%
|
-14%
|
-12,8%
|
-14,9%
|
Totale activa
1 |
324.937
|
407.090
|
129.334
|
114.519
|
191.762
|
136.726
|
Nettoactief per aandeel
2 |
2.365
|
858,0
|
320,0
|
1.051
|
768,0
|
558,0
|
Cashflow per aandeel
2 |
342,0
|
113,0
|
62,80
|
477,0
|
123,0
|
229,0
|
Capex
1 |
283
|
792
|
73,6
|
64,6
|
292
|
351
|
Capex/omzet
|
3,67%
|
8,73%
|
4,41%
|
25,38%
|
5,82%
|
8,92%
|
Datum van publicatie
|
19-03-19
|
30-03-20
|
22-03-21
|
22-03-22
|
23-03-23
|
21-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -39,88% | 276 mln. | | +16,45% | 122 mld. | | +21,96% | 116 mld. | | +24,66% | 27,03 mld. | | -20,05% | 20,36 mld. | | -16,28% | 15,91 mld. | | -16,40% | 16,43 mld. | | -44,35% | 15,6 mld. | | +63,91% | 14,94 mld. | | +2,52% | 13,59 mld. |
Biotherapeutische geneesmiddelen
|